Dr. Reddy’s Laboratories informs about asset purchase agreement of subsidiary company

17 Dec 2022 Evaluate

In compliance with Regulation 30 of SEBI Listing Regulations, Dr. Reddy’s Laboratories has informed that, Dr. Reddy's Research and Development B. V., a wholly owned subsidiary of the Company, has entered into an Asset Purchase Agreement for sale of its certain assets and liabilities including transfer of employees at site situated at Zernikedreef 12, 2333, CL Leiden, The Netherlands. The disclosure required under Regulation 30 of the SEBI Listing Regulations read with Circular is enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×